Rare diseases
Investigational molecules
Locations
Back to Italy79 clinical trials in Trento, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
ItalyStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
ItalyStudy on the Effects of Acetylcarnitine Hydrochloride in Patients with Amyotrophic Lateral Sclerosis (ALS)
ItalyStudy on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability
ItalyPhase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments
ItalyA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
ItalyCabozantinib Monitoring for Toxicity Management in Patients with Renal Cell Carcinoma
ItalyVMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk
ItalyStudy of teclistamab plus autologous lymphocyte infusion in patients with relapsed or refractory multiple myeloma
ItalyA study to evaluate if silymarin prevents liver damage caused by ribociclib in patients with hormone receptor positive, HER2-negative breast cancer
ItalyStudy of Piperacillin and Tazobactam Given Under the Skin Compared to a Vein in Patients with Infectious Diseases
ItalyA study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic castration-resistant prostate cancer, evaluating new therapeutic combinations and treatment sequences.
Studies are examining both early-stage and advanced disease management strategies.
Research initiatives exploring treatments for HER2-positive and HER2-low breast cancer, including studies for both early-stage and metastatic disease.
Particular focus on personalized treatment approaches for different breast cancer subtypes.
Comprehensive studies investigating treatments for lung cancer, melanoma, and urothelial cancer.
Focus on improving survival rates and quality of life for patients with various cancer types.
Innovative research in acute myocardial infarction management and prevention, with emphasis on emergency interventions.
Studies aim to improve rapid response and outcomes in cardiac emergencies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
